Home/Filings/4/0001209191-18-008069
4//SEC Filing

Baker Kevin Paul 4

Accession 0001209191-18-008069

CIK 0001175505other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 2:03 PM ET

Size

4.6 KB

Accession

0001209191-18-008069

Insider Transaction Report

Form 4
Period: 2018-02-05
Baker Kevin Paul
SVP, Development Sciences
Transactions
  • Tax Payment

    Common Stock

    2018-02-05$18.42/sh930$17,13174,684 total

Issuer

FIVE PRIME THERAPEUTICS INC

CIK 0001175505

Entity typeother

Related Parties

1
  • filerCIK 0001664512

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 2:03 PM ET
Size
4.6 KB